Literature DB >> 14687625

An in vivo propagated human acute myeloid leukemia expressing ABCA3.

Kevin Norwood1, Rui-Yu Wang, Charlotte Hirschmann-Jax, Michael Andreeff, Malcolm K Brenner, Margaret A Goodell, Gerald G Wulf.   

Abstract

Analyzing the regenerative compartment in the blast cell population of patients with acute myeloid leukemia (AML) may yield important insights into the mechanisms of disease progression. Here we present findings with a human AML cell line (AML-SP1), initiated from leukemic precursor cells and consecutively propagated by serial xenotransplantation in vivo. AML-SP1 maintained the characteristics of a human AML, consistently exhibiting a small leukemic side population (SP) of blast cells with high Hoechst 33342 exclusion. In the AML-SP1 line, an increased expression of the ABC transporters MDR1, MRP, ABCG2 and ABCA3 was found in the SP cells. The detection of ABCA3 in leukemic progenitor cells merits further investigation with regard to intracellular drug transport in AML blast cells. In vivo propagation of leukemias, such as AML-SP1 is a model system of maintaining the populational heterogeneity of AML disease, especially the unique characteristics of leukemic SP cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687625     DOI: 10.1016/j.leukres.2003.08.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

Review 1.  The ABCA subfamily--gene and protein structures, functions and associated hereditary diseases.

Authors:  Christiane Albrecht; Enrique Viturro
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

2.  ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.

Authors:  Bjoern Chapuy; Melanie Panse; Ulf Radunski; Raphael Koch; Dirk Wenzel; Nobuya Inagaki; Detlef Haase; Lorenz Truemper; Gerald G Wulf
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

3.  Inhibitor of DNA-binding 4 contributes to the maintenance and expansion of cancer stem cells in 4T1 mouse mammary cancer cell line.

Authors:  Se-Jin Park; Ran-Ju Kim; Jeong-Seok Nam
Journal:  Lab Anim Res       Date:  2011-12-19

4.  SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes.

Authors:  Ha-Won Jeong; Wei Cui; Youyang Yang; Jiayun Lu; Jie He; Ailing Li; David Song; Ye Guo; Bee H Liu; Li Chai
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study.

Authors:  Antony Ceraulo; Hélène Lapillonne; Meyling H Cheok; Claude Preudhomme; Hervé Dombret; Christine Terré; Juliette Lambert; Guy Leverger; Yves Bertrand; Franck Mortreux; Eric Wattel
Journal:  Blood Adv       Date:  2022-05-10

6.  The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.

Authors:  Qi Shen; Sichu Liu; Junyan Hu; Shaohua Chen; Lijian Yang; Bo Li; Xiuli Wu; Yu Ma; Jianchang Yang; Yupo Ma; Yangqiu Li
Journal:  Cancer Cell Int       Date:  2012-10-15       Impact factor: 5.722

7.  Constitutive expression of Wnt/β‑catenin target genes promotes proliferation and invasion of liver cancer stem cells.

Authors:  Wei Chen; Yu-Wei Zhang; Yang Li; Jian-Wen Zhang; Tong Zhang; Bin-Sheng Fu; Qi Zhang; Nan Jiang
Journal:  Mol Med Rep       Date:  2016-03-07       Impact factor: 2.952

8.  Aberrantly regulated dysadherin and B-cell lymphoma 2/B-cell lymphoma 2-associated X enhances tumorigenesis and DNA targeting drug resistance of liver cancer stem cells.

Authors:  Nan Jiang; Wei Chen; Jian-Wen Zhang; Yang Li; Xian-Cheng Zeng; Tong Zhang; Bin-Sheng Fu; Hui-Min Yi; Qi Zhang
Journal:  Mol Med Rep       Date:  2015-09-25       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.